These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8394443)

  • 1. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses.
    Reinhart TA; Ghosh AK; Hoover EA; Mullins JI
    J Virol; 1993 Sep; 67(9):5153-62. PubMed ID: 8394443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
    Moser M; Burns CC; Boomer S; Overbaugh J
    Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein.
    Poss ML; Quackenbush SL; Mullins JI; Hoover EA
    J Virol; 1990 Sep; 64(9):4338-45. PubMed ID: 2166820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
    Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
    J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.
    Donahue PR; Quackenbush SL; Gallo MV; deNoronha CM; Overbaugh J; Hoover EA; Mullins JI
    J Virol; 1991 Aug; 65(8):4461-9. PubMed ID: 1649341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
    Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
    J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins.
    Kristal BS; Reinhart TA; Hoover EA; Mullins JI
    J Virol; 1993 Jul; 67(7):4142-53. PubMed ID: 8389921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.
    Poss ML; Mullins JI; Hoover EA
    J Virol; 1989 Jan; 63(1):189-95. PubMed ID: 2535725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.
    Thomas E; Overbaugh J
    J Virol; 1993 Oct; 67(10):5724-32. PubMed ID: 8396654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV.
    Overbaugh J; Hoover EA; Mullins JI; Burns DP; Rudensey L; Quackenbush SL; Stallard V; Donahue PR
    Virology; 1992 Jun; 188(2):558-69. PubMed ID: 1316674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.
    Quackenbush SL; Donahue PR; Dean GA; Myles MH; Ackley CD; Cooper MD; Mullins JI; Hoover EA
    J Virol; 1990 Nov; 64(11):5465-74. PubMed ID: 1976822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
    Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
    J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication kinetics and cell tropism of an immunosuppressive feline leukaemia virus.
    Quackenbush SL; Mullins JI; Hoover EA
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1411-20. PubMed ID: 8757981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
    Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
    J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome.
    Bolin LL; Ahmad S; Levy LS
    Vet Immunol Immunopathol; 2011 Oct; 143(3-4):221-6. PubMed ID: 21764142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
    Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
    Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
    J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.